IRIS
SPINA, Edoardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.856
EU - Europa 12.432
AS - Asia 6.990
SA - Sud America 3.043
AF - Africa 216
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 12
Totale 35.572
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.623
RU - Federazione Russa 4.108
SG - Singapore 3.052
BR - Brasile 2.711
IE - Irlanda 2.090
CN - Cina 1.776
SE - Svezia 1.704
IT - Italia 1.207
HK - Hong Kong 921
UA - Ucraina 901
DE - Germania 868
FI - Finlandia 457
VN - Vietnam 414
GB - Regno Unito 341
IN - India 251
PL - Polonia 208
FR - Francia 172
AR - Argentina 117
CA - Canada 107
MX - Messico 86
BD - Bangladesh 73
TR - Turchia 73
NL - Olanda 72
ZA - Sudafrica 64
IQ - Iraq 59
BE - Belgio 58
ID - Indonesia 53
EC - Ecuador 52
ES - Italia 45
AT - Austria 42
MA - Marocco 42
JP - Giappone 40
UZ - Uzbekistan 40
CO - Colombia 36
PK - Pakistan 36
VE - Venezuela 36
CL - Cile 35
EE - Estonia 32
AE - Emirati Arabi Uniti 21
DZ - Algeria 20
AZ - Azerbaigian 19
CI - Costa d'Avorio 19
EG - Egitto 19
UY - Uruguay 18
KE - Kenya 17
LT - Lituania 17
AL - Albania 16
JO - Giordania 16
KZ - Kazakistan 16
AU - Australia 15
PY - Paraguay 15
TN - Tunisia 15
CZ - Repubblica Ceca 14
NP - Nepal 14
OM - Oman 14
PE - Perù 13
BG - Bulgaria 12
CH - Svizzera 12
IL - Israele 11
JM - Giamaica 11
PH - Filippine 11
IR - Iran 10
AM - Armenia 8
BO - Bolivia 8
GR - Grecia 8
KG - Kirghizistan 8
RO - Romania 8
SN - Senegal 8
DO - Repubblica Dominicana 7
KR - Corea 7
LB - Libano 7
LV - Lettonia 7
EU - Europa 6
PA - Panama 6
PS - Palestinian Territory 6
RS - Serbia 6
CR - Costa Rica 5
GE - Georgia 5
BN - Brunei Darussalam 4
ET - Etiopia 4
HN - Honduras 4
HR - Croazia 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
TW - Taiwan 4
BY - Bielorussia 3
DK - Danimarca 3
LK - Sri Lanka 3
MY - Malesia 3
NO - Norvegia 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
A1 - Anonimo 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
GA - Gabon 2
GY - Guiana 2
KH - Cambogia 2
Totale 35.544
Salva come PNG Salva come JPEG
Città #
Moscow 2.179
Dublin 2.087
Jacksonville 1.750
Dallas 1.695
Chandler 1.522
Singapore 1.511
Ashburn 1.287
Hong Kong 918
Beijing 815
Nyköping 751
Princeton 400
Cambridge 361
Dearborn 358
Los Angeles 294
Des Moines 278
Medford 247
Messina 230
Boardman 223
The Dalles 220
São Paulo 207
Ann Arbor 194
Buffalo 191
Warsaw 190
New York 185
Ho Chi Minh City 144
Munich 136
Hyderabad 133
Wilmington 124
Houston 94
Redondo Beach 94
Lancaster 93
Tianjin 88
Hanoi 87
Rio de Janeiro 86
Woodbridge 77
Jinan 75
Milan 74
Seattle 72
Turku 68
Belo Horizonte 67
San Mateo 64
Shenyang 64
Bremen 63
Brussels 57
Rome 57
Brasília 52
Nanjing 49
Pune 45
Curitiba 44
Frankfurt am Main 42
Montreal 41
Catania 38
Tashkent 36
Hangzhou 35
Hebei 34
Tokyo 34
Porto Alegre 33
Campinas 32
Haikou 32
Helsinki 32
Johannesburg 31
Santa Clara 31
Zhengzhou 30
Denver 29
Norwalk 29
Guangzhou 28
London 28
Baghdad 27
Stockholm 27
Taizhou 27
Brooklyn 26
Ningbo 26
Guarulhos 25
Recife 25
Vienna 25
Chennai 24
Nuremberg 24
Boston 23
Salvador 22
Amsterdam 21
Chicago 21
Contagem 21
Mexico City 21
Orem 21
Poplar 21
San Francisco 21
Washington 21
Biên Hòa 20
Changsha 20
Haiphong 20
Abidjan 19
Baku 19
Dhaka 19
Goiânia 19
Jakarta 19
Sorocaba 19
Dong Ket 18
Düsseldorf 18
Fortaleza 18
Guayaquil 18
Totale 21.410
Salva come PNG Salva come JPEG
Nome #
Efficacia di un trattamento aggiuntivo con olanzapina nel disturbo ossessivo-compulsivo resistente agli SSRI 370
Cutis verticis gyrata primitiva o pachidermia verticis gyrata: contributo clinico-istologico 325
Adverse Drug Reactions in Hospitalized patients: results of the FORWARD (Facilitation of reporting in hospital Ward) study. 214
Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study 206
A molecular pathway analysis informs the genetic background at risk for schizophrenia. 198
Aripiprazolo in bambini con ADHD in comorbidità con Disturbo da Tic 180
6-Mer Hyaluronan Oligosaccharides ModulateNeuroinflammation and a-Synuclein Expression inNeuron-Like SH-SY5Y Cells 178
Acute Cerebellar Ataxia Following Meningococcal Group C Conjugate Vaccination 177
Confronto Teofillina-Doxofillina nella risoluzione del broncospasmo 171
Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study 170
"Valproic acid-amitriptyline interaction in man 163
A comprehensive review of swallowing difficulties and dysphagia associated with antipsychotics in adults. 162
Augmentation con Lamotrigina in pazienti con schizofrenia resistente in trattamento con Clozapina 161
Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder 156
A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children 151
Antidepressant effect of hypericum perforatum extract on behaviour and neurogenesis in chronic corticosterone-treated mice. 150
Low-dose of bergamot-derived polyphenolic fraction (BPF) did not improve metabolic parameters in second generation antipsychotics-treated patients: Results from a 60-days open-label study 148
Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with attention-deficit hyperactivity disorder 147
Antidepressant use in the elderly: The role of pharmacodynamics and pharmacokinetics in drug safety 147
ABCB1 polymorphisms influence steady state plasma levels of 9-hydroxyrisperidone and risperidone active moiety. 146
Aripiprazole in Children with Multiple-complex Developmental Disorder (McDD): a case series. 146
Serenoa repens as an Endocrine Disruptor in a 10-Year-Old Young Girl: A New Case Report 146
Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity 144
Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenic patients 144
6-MERS HYALURONAN OLIGOSACCHARIDES STIMULATE INFLAMMATORY RESPONSE IN NEURONAL-LIKE DIFFERENTIATED SH-SY5Y NEUROBLASTOMA CELLS 144
Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003-2004. 141
Aripiprazole enhances the antidepressant effect of fluoxetine in mice. 141
Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. 141
A systematic review and combined analysis of therapeutic drug monitoring studies for long-acting risperidone. 141
A double-blind comparative study of bromperidol versus halperidol in schizophrenic patients 139
Uso dell’Aripiprazolo in bambini con Multiple-complex Developmental Disorder (McDD). 138
PATTERN PRESCRITTIVO DI FARMACI ANTIEPILETTICI NELL'ANZIANO: STUDIO DI POPOLAZIONE IN UN'AREA DEL SUD ITALIA NEGLI ANNI 2004-2007 137
ANTITHETIC ACTION OF HYALURONAN 6-MER IN UNDIFFERENTIATED AND DIFFERENTIATED SH-SY5Y CELLS 137
Generic Olanzapine Substitution in Patients with Schizophrenia: Assessment of Serum Concentrations and Therapeutic Response After Switching 137
Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database 136
Augmentation of clozapine with agomelatine in partial-responder schizophrenia: A 16-week, open-label, uncontrolled pilot study 136
Ototoxic adverse drug reactions: A disproportionality analysis using the Italian spontaneous reporting database 136
Adverse reactions related to proton pump inhibitors in pediatric population: an analysis of spontaneous reporting data 135
Aripiprazole enhances the antidepressat effect of fluoxetine in mice. 134
AN ENDOCRINOLOGIC STUDY OF PATIENTS WITH PRIMARY-CUTIS-VERTICIS GYRATA 133
Aripiprazole in Children with Multiple-complex Developmental Disorder (McDD): a case series. 132
Safety and tolerability of antipsychotic drugs in pediatric patients: data from an ongoing active pharmacovigilance study in Sicily 132
Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database 132
Effect of aripiprazole augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study. XVII Congresso Nazionale della Società Italiana di Neuropsicofarmacologia, Cagliari 22-25 Settembre 2010, p. 47. 130
Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. 130
No association between CYP2D6 polymorphism and Alzheimer's disease in an Italian population 129
ECG parameters in children and adolescents treated with aripiprazole and risperidone 129
Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population 128
A pharmacokinetic-pharmacodynamic method for predicting warfarin maintenance dose: preliminary results 128
A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care. 128
“Newer and older antiepileptic drug in southern Italy: a population based study during the years 2003-2005” 126
5-HT2A and 5-HT2C receptor polymorphisms and psychotic symptoms in Alzheimer's disease 126
ADJUNCTIVE FLUOXETINE IN THE TREATMENT OF NEGATIVE SYMPTOMS IN CHRONIC-SCHIZOPHRENIC PATIENTS 125
Acute cerebellar ataxia following meningococcal group C conjugate vaccination 125
Effect of aripiprazole augmentation of clozapine in schizophrenia: A double-blind, placebo-controlled study. 123
Antidepressant drugs and seizure susceptibility: From in vitro data to clinical practice 122
Risperidone treatment of children with autistic disorder: Effectiveness, tolerability, and pharmacokinetic implications 122
Clinically Relevant Drug Interactions with Anti-Alzheimer's Drugs. 122
Early atypical injection-site reactions to COVID-19 vaccine: a case series 120
Interazione farmacocinetica tra mirtazapina e clozapina in pazienti schizofrenici. 120
Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. 120
Aripiprazole augmentation of serotinin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study 120
Efficacia e tollerabilità della quetiapina vs. clozapina in pazienti anziani parkinsoniani con psicosi dopaminergica. 120
Clinically Relevant Drug Interactions Between Statins and Antidepressants 120
Effetto di un trattamento con risperidone o olanzapina sui livelli serici di prolattina in bambini e adolescenti con patologie psichiatriche. 119
Duloxetine as adjunctive treatment to clozapine in patients with schizophrenia: a randomized, placebo-controlled trial. 119
“Augmentation con Duloxetina vs. placebo in un campione di schizofrenici partial responders in trattamento stabilizzato con antipsicotici atipici”. 118
Effects of aripiprazole and risperidone on ventricular repolarization in children and adolescent. 118
Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies 118
Pediatric adverse reactions to antiseizure medications – An analysis of data from the Italian spontaneous reporting system (2001–2019) 118
Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project 117
Real world use of biological drugs in patients with psoriasis/psoriatic arthritis: a retrospective, population-based study from Southern Italy in the years 2010-2014 117
Drug-induced urinary retention: an analysis of a national spontaneous adverse drug reaction reporting database 117
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety 116
Age-related changes in pharmacodynamics: focus on drug acting on cetral nervous and cardiovascular systems 115
Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database 115
Augmentation of Clozapine With Ziprasidone in Refractory Schizophrenia: A Double-Blind, Placebo-Controlled Study. 113
PARKINSONISMO ED INIBITORI SELETTIVI DEL REUPTAKE DELLA SEROTONINA 112
Impiego clinico del Risperidone in età evolutiva: variazioni farmacocinetiche e cliniche 112
USE AND TOLERABILITY OF NEWER ANTIPSYCHOTICS AND ANTIDEPRESSANTS: A CHART REVIEW IN A PAEDIATRIC SETTING. 112
Effect of valpromide on the pharmacokinetics of Carbamazepine-10,11-epoxide 112
Tossicità cardiovascolare degli antipsicotici atipici in età evolutiva 112
Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011 112
n-3 fatty acids prevent impairment of neurogenesis and synaptic plasticity in B-cell (BAFF) transgenic mice 111
Safety and tolerability of psychotropic medications in childhood: preliminary data of a pharmacovigilance study 111
Effectiveness and safety profile of mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a tertiary care 109
“Effect of valproic acid on plasma concentrations of olanzapine in patients with psychiatric disorders” 109
Prescribing pattern of antiepileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-2007 109
Effect of adjunctive duloxetine on the plasma concentrations of clozapine, olazapine and risperidone I patients with psychotic disorders 109
Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study 109
Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics 108
Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis 108
Estimating the effects of co-medications on plasma olanzapine concentrations by using a mixed model. 107
Newer and older antiepileptic drug use in Southern Italy: a population-based study during the years 2003-2005. 107
Quetiapine versus clozapine: a preliminary report of comparative effects on dopaminergic psychosis in patients with Parkinson's disease 106
Pharmacokinetic interaction between duloxetine and second-generation antipsychotics in patients with psychotic disorders 106
Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with Attention Deficit Hyperactivity Disorder 106
Effect of topiramate on plasma concentrations of clozapine, olanzapine, risperidone, and quetiapine in patients with psychotic disorders 105
Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: A follow-up of two years 105
Neuropsychiatric reactions to drugs: an analysis of spontaneous reports from general practitioners in Italy. 105
Totale 13.537
Salva come PNG Salva come JPEG
Categoria #
all - tutte 131.276
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 131.276
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.265 0 0 0 0 0 299 56 243 56 338 133 140
2021/20222.228 27 225 31 78 50 23 133 114 83 446 293 725
2022/20235.906 509 412 218 480 521 543 52 347 2.554 28 176 66
2023/20241.672 121 246 109 169 168 338 70 102 26 164 19 140
2024/20257.254 96 95 156 401 381 220 137 1.647 1.938 446 582 1.155
2025/202611.455 911 1.411 1.804 1.471 1.592 4.266 0 0 0 0 0 0
Totale 35.990